Heart Disease Trial, Recruiting NCT02798276 Sponsor: Antoni Bayés Genís Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT02798276
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old and able to give their own consent to participate
  • People who have a specific pattern called a "Q wave" showing on their heart tracing (ECG)
  • People who have had a heart attack that has affected at least 50% of the thickness of a section of heart muscle, confirmed by MRI scan, where the affected area cannot be treated by reopening the blocked blood vessel (either because of how damaged the muscle is or because of the condition of the vessel)
  • People who are already being considered for bypass surgery to treat other areas of the heart

Who may not be able to join:

  • People who have a serious non-heart-related illness that is expected to reduce their life expectancy to less than one year
  • People who have severe heart valve disease that is being considered for surgical repair
  • People who are being considered for a procedure to reshape or reconstruct the heart's main pumping chamber
  • People for whom an MRI scan is not safe or suitable (confirm with trial site)
  • People with severe kidney or liver failure
  • People with abnormal blood test results that cannot be explained at the time of joining the trial
  • People who have previously had a heart procedure or heart surgery
  • People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Antoni Bayés Genís
Registry
ClinicalTrials.gov
Start date
1 March 2017
Est. completion
1 October 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Changes in necrotic mass ratio (%) by gadolinium retention.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov